Digital health firm Altibbi raises Rs 334 crore in series B round
Dubai: Altibbi, a Middle East digital health platform founded in Jordan and headquartered in Dubai, has raised $44 million in a series B round to expand its online pharmacy and diagnostic collection business, it said in a statement on Monday.The funding round was led by Dubai-headquartered Foundation Holdings and the venture capital arm of Hikma Pharmaceuticals, Hikma Ventures, as well...
Login or Register to read the full article
Dubai: Altibbi, a Middle East digital health platform founded in Jordan and headquartered in Dubai, has raised $44 million in a series B round to expand its online pharmacy and diagnostic collection business, it said in a statement on Monday.
The funding round was led by Dubai-headquartered Foundation Holdings and the venture capital arm of Hikma Pharmaceuticals, Hikma Ventures, as well as existing investors Dubai-based Global Ventures and Amman-based DASH Ventures.
"Our objective is to support Altibbi to reach a superior position where its quality, exponential growth and trusted brand will enable them to be the first publicly listed digital health unicorn IPO in the GCC," Foundation Holdings Chief Executive Abhishek Sharma said in the statement, referring to the six-nation Gulf Cooperation Council.
Other Altibbi shareholders include Endeavor Catalyst, Middle East Venture Partners and Al Rashed, the firm said. Investment bank Awad Capital advised Altibbi on the fundraising.
Foundation Holdings senior advisor Jason Kothari will join Altibbi's board, Altibbi said.
Read also: Tata Capital Healthcare Fund raises Rs 955 crore fund
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd